Dr. Hitesh Chawla, MD

Dr. Chawla practices at Premier Medical Group of the Hudson Valley in Poughkeepsie, New York.

Dr. Chawla's NPI, 1023450319, was assigned on July 27, 2013. Dr. Chawla holds Maryland license D89335.

Dr. Chawla's primary practice is Premier Medical Group of the Hudson Valley, at 82 Washington St, Poughkeepsie, NY 12601 in Dutchess County. The practice phone is (845) 437-5000.

Dr. Chawla's primary practice is Premier Medical Group of the Hudson Valley in Poughkeepsie, New York. Dr. Chawla is also affiliated with Tucson Medical Center. The medical group on file is Premier Medical Group of the Hudson Valley. Dmand AI also links Dr. Chawla to 1 more hospital, 4 medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chawla practices, 4 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Chawla's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Chawla is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Chawla's licenses on file in 2 states: Maryland and Illinois.

CMS data shows 407 Medicare services from Dr. Chawla across 9 procedure codes in 2024, for 247 Medicare patients. Medicare paid $24,142 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 247 Medicare patients who saw Dr. Chawla in 2024. The largest group is 75 to 84, with 101 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 2.00, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chawla's median patient age at 67, with 49% women.

In 2024, Dr. Chawla wrote 29 Medicare Part D claims for 15 patients. 90% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $11,341 in total drug cost. In 2022, CMS named 540 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Chawla for performance year 2024, reported as part of a group. Dr. Chawla accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 40 procedures of coronary angioplasty and stenting by Dr. Chawla, more than 76% of the clinicians it reports for that procedure.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Dr. Chawla, published from 2021 to 2022. Dr. Chawla's most frequent co-authors are Rami Doukky, MD, Neeraj Jolly, MD and Kameel Kassab, MD.

CMS Open Payments shows 35 general payments to Dr. Chawla from 16 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 88% of the total. Abiomed paid the most, $410.